Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

An in-depth analysis of pathogenesis of SARS-CoV-2 and therapeutic options for COVID-19

An in-depth analysis of pathogenesis of SARS-CoV-2 and therapeutic options for COVID-19

3 Apr 2022
Bats carry some of the most virulent, but not the most dangerous zoonotic viruses

Bats carry some of the most virulent, but not the most dangerous zoonotic viruses

3 Apr 2022
Study investigates messenger ribonucleic acid-based SARS-CoV-2 vaccine efficacy against SARS-CoV-2 Omicron in Denmark

Study investigates messenger ribonucleic acid-based SARS-CoV-2 vaccine efficacy against SARS-CoV-2 Omicron in Denmark

1 Apr 2022
Researchers explore a novel method to isolate monoclonal antibodies from COVID-19 convalescents infected with SARS-CoV-2 variants

Researchers explore a novel method to isolate monoclonal antibodies from COVID-19 convalescents infected with SARS-CoV-2 variants

1 Apr 2022
Study finds COVID-19 convalescent children had more robust humoral immune responses to SARS-CoV-2 than convalescent adults

Study finds COVID-19 convalescent children had more robust humoral immune responses to SARS-CoV-2 than convalescent adults

1 Apr 2022
Scientists evaluate the SARS-CoV-2 neutralizing ability of two-dose BNT162b2 vaccination

Scientists evaluate the SARS-CoV-2 neutralizing ability of two-dose BNT162b2 vaccination

1 Apr 2022
Study explores molecular mechanisms underlying SARS-CoV-2 infection of macrophages and the induction of pro-inflammatory cytokines

Study explores molecular mechanisms underlying SARS-CoV-2 infection of macrophages and the induction of pro-inflammatory cytokines

1 Apr 2022
Study identifies a new class of monoclonal antibodies that neutralize both alpha and beta coronaviruses

Study identifies a new class of monoclonal antibodies that neutralize both alpha and beta coronaviruses

1 Apr 2022
TMPRSS2 inhibitor found to be a novel and effective therapeutic option against pan-variant SARS-CoV-2 infections

TMPRSS2 inhibitor found to be a novel and effective therapeutic option against pan-variant SARS-CoV-2 infections

1 Apr 2022
No evidence of SARS-CoV-2 in the U.K.'s wild deer population

No evidence of SARS-CoV-2 in the U.K.'s wild deer population

31 Mar 2022
The longest duration of SARS-CoV-2 positivity after initial diagnosis

The longest duration of SARS-CoV-2 positivity after initial diagnosis

31 Mar 2022
The mucosal antibody response to SARS-CoV-2

The mucosal antibody response to SARS-CoV-2

31 Mar 2022
How effective are household cleaning agents against SARS-CoV-2?

How effective are household cleaning agents against SARS-CoV-2?

31 Mar 2022
The evolution of the SARS-CoV-2 spike protein

The evolution of the SARS-CoV-2 spike protein

31 Mar 2022
Scientists explore impact of SARS-CoV-2 natural immunity on vaccine-induced immunity

Scientists explore impact of SARS-CoV-2 natural immunity on vaccine-induced immunity

31 Mar 2022
Risk of breakthrough infections by SARS-CoV-2 Omicron and Delta variants in fully vaccinated adults

Risk of breakthrough infections by SARS-CoV-2 Omicron and Delta variants in fully vaccinated adults

31 Mar 2022
Study identifies implications of long-COVID on long term physical and mental health

Study identifies implications of long-COVID on long term physical and mental health

31 Mar 2022
Impact of racial disparities on COVID-19 outcomes

Impact of racial disparities on COVID-19 outcomes

31 Mar 2022
Study estimates the comparative abundance of SARS-CoV-2 variants via wastewater monitoring

Study estimates the comparative abundance of SARS-CoV-2 variants via wastewater monitoring

31 Mar 2022
Study determines the molecular signatures of monocytes and regulatory T cells in the circulating blood of COVID-19 patients

Study determines the molecular signatures of monocytes and regulatory T cells in the circulating blood of COVID-19 patients

31 Mar 2022

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback